Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization

被引:0
|
作者
Kuang, Donglin [1 ]
Zhang, Nan [1 ]
Zhang, Mengfan [1 ]
Li, Hao [1 ]
Han, Xinwei [1 ]
Ren, Jianzhuang [1 ]
Duan, Xuhua [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Henan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; drug-eluting bead transcatheter arterial chemoembolization; magnetic resonance imaging; margin enhancement; morphology; MICROVASCULAR INVASION; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC-TUMORS; ABLATION; CT; MR; MICROSPHERES; PREDICTION; SURVIVAL; CANCER;
D O I
10.3389/fonc.2023.957710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE). MethodsFrom January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded. ResultsIn the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of >= 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05). ConclusionsPatients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis
    Han, Tao
    Yang, Xiaodan
    Zhang, Yue
    Li, Gao
    Liu, Lu
    Chen, Tingsong
    Zheng, Zhendong
    BIOSCIENCE TRENDS, 2019, 13 (05) : 374 - 381
  • [22] Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE)
    Nakano, Mariko M.
    Yamamoto, Akira
    Nishida, Norifumi
    Hamuro, Masao
    Hamamoto, Shinichi
    Jogo, Atsushi
    Sohgawa, Etsuji
    Kageyama, Ken
    Minami, Tetsuya
    Miki, Yukio
    JAPANESE JOURNAL OF RADIOLOGY, 2019, 37 (07) : 543 - 548
  • [23] Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization
    Ray, Charles E., Jr.
    Brown, Anthony C.
    Green, Tyler J.
    Winston, Helena
    Curran, Casey
    Kreidler, Sarah M.
    Glueck, Deborah H.
    Rochon, Paul J.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 204 (02) : 440 - 447
  • [24] Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma
    Iezzi, Roberto
    Pompili, Maurizio
    La Torre, Michele Fabio
    Campanale, Maria Chiara
    Montagna, Martina
    Saviano, Antonio
    Cesario, Valentina
    Siciliano, Massimo
    Annicchiarico, Eleonora
    Agnes, Salvatore
    Giuliante, Felice
    Grieco, Antonio
    Rapaccini, Gian Lodovico
    De Gaetano, Anna Maria
    Gasbarrini, Antonio
    Bonomo, Lorenzo
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (03) : 242 - 248
  • [25] Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization
    Fujita, Masashi
    Okai, Ken
    Hayashi, Manabu
    Abe, Kazumichi
    Takahashi, Atsushi
    Kimura, Takashi
    Kenjo, Akira
    Marubashi, Shigeru
    Hashimoto, Yuko
    Ohira, Hiromasa
    INTERNAL MEDICINE, 2019, 58 (08) : 1103 - 1110
  • [26] Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
    Kloeckner, Roman
    Weinmann, Arndt
    Prinz, Friederike
    dos Santos, Daniel Pinto
    Ruckes, Christian
    Dueber, Christoph
    Pitton, Michael Bernhard
    BMC CANCER, 2015, 15
  • [27] Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
    Yi-Sheng Liu
    Chia-Ying Lin
    Ming-Tsung Chuang
    Chia-Ying Lin
    Yi-Shan Tsai
    Chien-Kuo Wang
    Ming-Ching Ou
    BMC Gastroenterology, 18
  • [28] Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
    Adel, Hatem
    Shazlee, Muhammad K.
    Qamar, Saqib
    Hyder, Syed Muhammad Shahnawaz
    Razaque, Abdul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [29] Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
    Ji, Kun
    Zhu, Hanlong
    Wu, Wei
    Li, Xin
    Zhan, Pengchao
    Shi, Yang
    Sun, Junhui
    Li, Zhen
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 537 - 551
  • [30] Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
    Chang, Wei-Chou
    Hsu, Hsian-He
    Chiu, Sung-Hua
    Huang, Wen-Yen
    Lo, Cheng-Hsiang
    Lin, Hsuan-Hwai
    Huang, Pei-Ching
    Shih, Yu-Lueng
    Wan, Yung-Liang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 937 - 949